Endoglin/CD 105 may not be an optimal tumor endothelial treatment target [1]

A. W. Griffioen; C. A. Damen; G. H. Blijham; G. Groenewegen

doi:10.1007/BF01806191

Endoglin/CD 105 may not be an optimal tumor endothelial treatment target [1]

A. W. Griffioen^*, C. A. Damen, G. H. Blijham, G. Groenewegen

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

16 Citations (Scopus)

Original language	English
Pages (from-to)	239-240
Number of pages	2
Journal	Breast Cancer Research and Treatment
Volume	39
Issue number	2
DOIs	https://doi.org/10.1007/BF01806191
Publication status	Published - 1 Jan 1996

Access to Document

10.1007/BF01806191

Cite this

@article{45948cc5d4524c3da90732c0a81a24cf,

title = "Endoglin/CD 105 may not be an optimal tumor endothelial treatment target [1]",

author = "Griffioen, {A. W.} and Damen, {C. A.} and Blijham, {G. H.} and G. Groenewegen",

year = "1996",

month = jan,

day = "1",

doi = "10.1007/BF01806191",

language = "English",

volume = "39",

pages = "239--240",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

number = "2",

}

TY - JOUR

T1 - Endoglin/CD 105 may not be an optimal tumor endothelial treatment target [1]

AU - Griffioen, A. W.

AU - Damen, C. A.

AU - Blijham, G. H.

AU - Groenewegen, G.

PY - 1996/1/1

Y1 - 1996/1/1

UR - http://www.scopus.com/inward/record.url?scp=0029788738&partnerID=8YFLogxK

U2 - 10.1007/BF01806191

DO - 10.1007/BF01806191

M3 - Comment/Letter to the editor

C2 - 8872333

AN - SCOPUS:0029788738

SN - 0167-6806

VL - 39

SP - 239

EP - 240

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 2

ER -

Endoglin/CD 105 may not be an optimal tumor endothelial treatment target [1]

Access to Document

Other files and links

Cite this